Literature DB >> 16924045

The cutting edge: Thalidomide for type 1 cryoglobulinemic vasculopathy.

Alia Sampson1, Jeffrey P Callen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924045     DOI: 10.1001/archderm.142.8.972

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  1 in total

1.  Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.

Authors:  Richard J Lin; James J Curran; Todd M Zimmerman; Jie Song; Timothy B Niewold; Nadera J Sweiss
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.